Medtronic (MDT) Operating Expenses (2013 - 2026)

Medtronic (MDT) has 14 years of Operating Expenses data on file, last reported at $3.6 billion in Q2 2026.

• For the quarter ending Q2 2026, Operating Expenses fell 3.26% year-over-year to $3.6 billion; the trailing twelve-month figure through Apr 2026 stood at $14.8 billion (up 5.21% YoY), and the FY2026 full-year result was $14.8 billion, up 6.27% from the prior year.
• Operating Expenses retreated to $3.6 billion in Q2 2026, from $3.8 billion in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $3.8 billion in Q1 2026 to a low of $3.3 billion in Q1 2022.
• A 5-year average of $3.5 billion and a median of $3.5 billion in 2023 frame the typical range for Operating Expenses.
• Peak annual rise in Operating Expenses reached 12.08% in 2026, while the deepest fall reached 3.26% in 2026.
• Tracing MDT's Operating Expenses over 5 years: stood at $3.4 billion in 2022, then climbed by 2.57% to $3.5 billion in 2023, then grew by 0.72% to $3.5 billion in 2024, then advanced by 6.63% to $3.7 billion in 2025, then retreated by 3.8% to $3.6 billion in 2026.
• Business Quant data shows MDT's Operating Expenses at $3.6 billion in Q2 2026, $3.8 billion in Q1 2026, and $3.7 billion in Q4 2025.